Clinical trial
Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in…
NCT00210002 · Institut Claudius Regaud, Other · Terminated
Key facts
| NCT number | NCT00210002 |
|---|---|
| Title | Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced |
| Official title | Evaluation of Systematic Intravenous Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced. |
| Lead sponsor | Institut Claudius Regaud, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasms, Anemia |
| Intervention type | Drug |
| Interventions | Darbepoetin alfa (Aranesp®), Ferric saccharose(Venofer®) |
| Enrollment | 55 |
| Start date | Nov 1, 2003 |
| Completion | Apr 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 14, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: